The dorsogluteal site sits in the upper outer quadrant of the buttock, over the large gluteus maximus and gluteus medius muscles. For decades it was the default target for intramuscular injections, and many healthcare workers still use it routinely. But its anatomy puts it uncomfortably close to the sciatic nerve and the superior gluteal artery, which is why a growing body of evidence favors moving to a different spot on the hip altogether.
Locating the Site on Your Own Body
If you place your hand flat on one buttock, the dorsogluteal site lies in the superior lateral area of the gluteal muscles, roughly in the upper outer quarter of the buttock cheek.1PubMed Central. Adverse effects of dorsogluteal intramuscular injection versus ventrogluteal intramuscular injection: A systematic review and meta‐analysis The traditional way to find it is to draw an imaginary cross over the buttock: one line runs from the top of the gluteal cleft (the crease between the cheeks) to the bony point of the hip, and the other line runs horizontally across. The injection goes into the upper outer quadrant formed by those two lines. Healthcare workers sometimes also palpate the posterior superior iliac spine and the greater trochanter (the bony bump at the top of the thigh) and aim for a zone between them.
The problem is that this landmarking method leaves a lot of room for error. Bodies vary, and the imaginary-cross technique depends on the clinician estimating where the quadrant boundaries fall. Poor landmarking often results in improperly placed injections, especially when the person giving the shot is less experienced or working quickly.2PubMed. Dorsogluteal intramuscular injection depth needed to reach muscle tissue according to body mass index and gender: A systematic review Move too far toward the center and you risk hitting the sciatic nerve. Move too far down and the same nerve is at risk again. That margin of error is one of the central reasons the site has fallen out of favor in clinical guidelines.
What Sits Underneath the Needle
The dorsogluteal area is anatomically crowded. Two structures in particular make it hazardous compared with other injection sites.
The sciatic nerve, the thickest nerve in the body, runs through the deep buttock roughly in the lower and medial portion of the gluteal region. An accidental injection into or near the sciatic nerve can cause radicular pain and numbness with almost immediate onset, along with variable degrees of motor and sensory loss.3PubMed. A treatment option for post-injection sciatic neuropathy: transsacral block with methylprednisolone In severe cases, the resulting nerve injury can leave someone with a permanent foot drop or chronic pain. Intramuscular injection is the single most common mechanism for sciatic nerve injury of this kind.
The superior gluteal artery also passes through the region. Piercing it can produce a deep hematoma, and because the gluteal muscles are thick and well-supplied with blood, bleeding can be difficult to control with simple pressure. One case report traces a chain of events from a dorsogluteal injection to a hematoma, an abscess, and eventually a systemic inflammatory response, illustrating how quickly a vascular complication can escalate.4PubMed Central. Injection, hematoma, abscess, systemic inflammatory response syndrome, stairway to hell: Case report Researchers have criticized the dorsogluteal site specifically because of the combined risk of damaging both major nerves and blood vessels in a single region.
The Fat Layer Problem
An intramuscular injection only works if the medication actually reaches muscle. The buttock carries a substantial layer of subcutaneous fat, and at the dorsogluteal site that layer is often thick enough to prevent a standard-length needle from getting through.
A study measuring tissue thickness found that the average fat layer at the dorsogluteal site was about 35 mm in overweight adults, about 40 mm in obese adults, and over 50 mm in extremely obese adults. The numbers translated into a striking practical finding: injections given at this site would fail to reach muscle in roughly 98% of women and 37% of men.5PubMed. Does obesity prevent the needle from reaching muscle in intramuscular injections? When medication is deposited into fat rather than muscle, it absorbs more slowly and less predictably. For drugs with narrow dosing windows or time-sensitive effects, that can undermine the whole point of choosing an intramuscular route in the first place.
The ventrogluteal site, located on the side of the hip, fares somewhat better in this regard. Research on older adults found that while both sites met general tissue-thickness thresholds considered acceptable for intramuscular injection, the ventrogluteal site had greater muscle thickness and a thinner layer of subcutaneous fat.6PubMed. Examining the Safety of Dorsogluteal and Ventrogluteal Sites for Intramuscular Injection in Older Adults That combination means medication is more likely to land in muscle and absorb the way it should.
How the Ventrogluteal Site Differs
The ventrogluteal site sits on the lateral hip, over the gluteus medius and minimus muscles. To find it, a clinician places the heel of their hand on the greater trochanter (the bony prominence you can feel at the side of your hip), then spreads their index and middle fingers to form a V pointing toward the iliac crest, the curved ridge of bone at the top of the pelvis. The injection goes into the center of that V. Unlike the dorsogluteal site, this area has no major nerves or arteries running through it, and the overlying fat tends to be thinner.
A systematic review and meta-analysis comparing the two sites across multiple studies found that ventrogluteal injections were associated with significantly less pain, less bleeding, and fewer hematomas both 48 and 72 hours after injection.1PubMed Central. Adverse effects of dorsogluteal intramuscular injection versus ventrogluteal intramuscular injection: A systematic review and meta‐analysis Pain reduction matters not just for patient comfort but for willingness to receive future injections, which is relevant for people on long-term injectable medications such as antipsychotics or hormone therapy.
The ventrogluteal site is not without its own learning curve. The landmarks require placing your hands on the patient’s hip in a specific way, which can feel unfamiliar to clinicians trained exclusively on the dorsogluteal quadrant method. But the anatomical payoff is real: fewer critical structures underneath, a more reliable depth of muscle, and better clinical outcomes by the measures researchers have tested so far.
Why Clinicians Still Default to the Dorsogluteal Site
Given the evidence, you might wonder why the dorsogluteal site is used at all. The answer is mostly institutional inertia. Surveys of nurses have found that before targeted training interventions, over three-quarters of nurses reported using the dorsogluteal area as their go-to site, while fewer than one in ten chose the ventrogluteal region.7PubMed. An evaluation of the effectiveness of a planned training program for nurses on administering intramuscular injections into the ventrogluteal site Nursing education has been a big part of the problem: for roughly four decades, textbooks and educators taught the dorsogluteal site as the standard. Even as newer curricula began recommending the ventrogluteal site, students entering clinical rotations rarely saw experienced nurses using it.8Journal of Psychiatric and Mental Health Nursing. Intramuscular injections: a review of best practice for mental health nurses The disconnect between classroom instruction and ward practice has created a cycle that is slow to break.
Familiarity also plays a role in confidence. Nurses who have given thousands of dorsogluteal injections without an obvious complication understandably feel that the site is safe enough. Sciatic nerve injuries are uncommon on a per-injection basis, so many clinicians go an entire career without seeing one. That does not mean the risk is negligible across the millions of intramuscular injections given each year, but it does explain why individual practitioners may not feel urgency to change. The debate over whether the dorsogluteal site should be completely abandoned in favor of the ventrogluteal site continues in the nursing literature, with strong voices on both sides.9PubMed. The dorso-ventro debate: in search of empirical evidence
When Aspiration Still Matters
Aspiration is the step where a clinician pulls back on the syringe plunger after inserting the needle, checking for blood before injecting the medication. If blood appears, the needle may be in a blood vessel rather than muscle tissue. For most injection sites, guidelines have moved away from routine aspiration because the risk of hitting a vessel is extremely low and the extra step increases pain. But the dorsogluteal site is the exception. Because of its proximity to the gluteal artery, aspiration is still recommended when using this site.10PubMed. Aspirating during the intramuscular injection procedure: a systematic literature review
At the ventrogluteal, deltoid, and vastus lateralis sites, there is no clinical reason to aspirate. This is one more practical advantage of using an alternative site: it simplifies the procedure and reduces discomfort for the patient. For clinicians who already skip aspiration as a matter of habit, using the dorsogluteal site without it introduces a vascular risk they may not be accounting for.
The Dorsogluteal Site in Children
In young children, the dorsogluteal site carries additional concern. Children under about ten years old have gluteal muscles that are not yet fully developed, which means the sciatic nerve sits closer to the surface and is easier to hit. Evidence supports excluding the dorsogluteal site for children in this age range specifically to avoid sciatic nerve damage.9PubMed. The dorso-ventro debate: in search of empirical evidence For infants and toddlers, the anterolateral thigh (the outer middle portion of the upper leg) is the preferred site for vaccinations and other intramuscular injections because the muscle there is more developed relative to body size and is far from major nerves.
Pediatric injection injuries carry serious medicolegal weight. A study evaluating children with injection-related nerve damage who were referred for forensic medical evaluation highlighted that accurate technique and thorough documentation are critical for preventing both lifelong disability and subsequent litigation.11Turkish Journal of Medical Sciences. Medicolegal evaluation of pediatric patients with injection neuropathy When a child ends up with a foot drop or chronic neuropathic pain from a buttock injection, the legal question often comes down to whether the clinician chose an appropriate site and used proper landmarks.
Diagnosing a Nerve Injury After Injection
If you receive an injection at the dorsogluteal site and immediately feel shooting pain down your leg, tingling in your foot, or sudden weakness, those are warning signs of sciatic nerve injury. The symptoms can range from mild and temporary to severe and permanent. Diagnosis typically involves a clinical examination combined with electrodiagnostic tests, including nerve conduction studies and needle electromyography, which help pinpoint the location and severity of the damage.12Korean Journal of Pain. The relationship between nerve conduction studies and neuropathic pain in sciatic nerve injury due to intramuscular injection
Treatment depends on how badly the nerve was affected. Mild cases sometimes resolve with time and physical therapy. More severe injuries can require nerve blocks, corticosteroid injections near the affected nerve, or surgical intervention. Full recovery is not guaranteed, and some patients are left with permanent deficits. The contrast between this potential outcome and the relative simplicity of using a safer injection site is part of what drives the push to retire the dorsogluteal approach.
Other Injection Sites Worth Knowing About
Beyond the ventrogluteal and dorsogluteal areas, two other sites are commonly used for intramuscular injections, each with its own profile.
The deltoid, the rounded muscle capping the shoulder, is the standard site for most vaccinations in adults. It is easy to access, has a thin fat layer in most people, and is far from any critical nerves. The main limitation is volume: the deltoid can only accommodate about one to two milliliters of fluid, so it is not suitable for larger-volume injections.
The vastus lateralis, the outer muscle of the thigh, is the go-to for infants and small children and is also used in adults. Research using cadaver dissection and imaging in young adults confirmed that the middle portion of the vastus lateralis is largely free of major blood vessels and nerves, making it a reliably safe target.13PubMed Central. Anatomically safe sites for intramuscular injections: a cross-sectional study on young adults and cadavers with a focus on the thigh The thigh can handle larger volumes than the deltoid and is accessible without requiring the patient to remove lower garments in the way a gluteal injection does.
What This Means If You Are Receiving an Injection
You are well within your rights to ask a nurse or other clinician which site they plan to use for your intramuscular injection. If they reach for your upper outer buttock, you can ask whether the ventrogluteal site or another alternative would be appropriate. Most medications that have traditionally been given at the dorsogluteal site can be given at the ventrogluteal or deltoid site instead, depending on the volume and type of drug.
For people who receive regular intramuscular injections, like long-acting antipsychotics, hormone injections, or vitamin B12 shots, the choice of site adds up over time. Repeated injections at the dorsogluteal site can lead to tissue hardening, localized pain, and the cumulative risk of hitting a structure that should have been avoided. Rotating among safer sites reduces these problems and keeps the injection experience more tolerable over months and years.
If you are a larger-bodied person, the fat-layer issue is especially worth considering. As the tissue-thickness data show, a standard needle at the dorsogluteal site will fail to reach muscle in the vast majority of women regardless of body size, and in a substantial fraction of men once weight rises above average.5PubMed. Does obesity prevent the needle from reaching muscle in intramuscular injections? An injection that ends up in fat instead of muscle is not dangerous in the same way a nerve hit is, but it means the drug may not work as intended. Asking about needle length and site selection is a reasonable step toward making sure your medication actually does what it is supposed to do.